Ivonescimab shows survival benefit in lung cancer study
Go back to Ivonescimab shows survival benefit in lung cancer study| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 14.13 -0.03 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.16 | 52 Week High | $19.75 | |||
| Open | $14.15 | 52 Week Low | $4.26 | |||
| Day High | $14.72 | P/E | N/A | |||
| Day Low | $14.06 | EPS | $0.00 | |||
| Volume | 1,086,197 | |||||
